{"entity":{"type":"insider","cik":"0001766516","url":"/insider/0001766516","json_url":"/insider/0001766516.json","name":"Ally Bridge MedAlpha Management L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":6,"first":"2020-12-16","last":"2021-01-05","span_basis":"filed_date"},"name_variants":[{"name":"Ally Bridge MedAlpha Management L.P.","source":"filing","n_filings":6,"first_seen":"2020-12-16","last_seen":"2021-01-05"}],"transactions":[{"id":5130608,"accession":"0000899243-21-000379","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-000379","line_url":"/filing/0000899243-21-000379","is_derivative":false,"issuer_cik":"0001402479","issuer_name":"MedAvail Holdings, Inc.","issuer_ticker":"MDVL","issuer_name_source":null,"issuer_url":"/issuer/0001402479","owner_cik":null,"owner_name":"Ally Bridge MedAlpha Master Fund L.P.; ABG-WTT Global Life Science Capital Partners GP, L.P.; Ally Bridge Group (NY) LLC; Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.; ABG WTT-MedAvail Ltd; Ally Bridge MedAlpha Management L.P.; Ally Bridge MedAlpha Management GP, LLC; Yu Fan; ABG Management Ltd.; ABG-WTT Global Life Science Capital Partners GP Ltd","owner_display_name":"Ally Bridge MedAlpha Master Fund L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12670.0,"shares_display":"12,670","price_per_share":14.9959,"price_display":"15.00","price_state":"stated","total_value":189998.053,"total_display":"189,998.05","total_whole":"189,998","shares_owned_after":3885951.0,"shares_owned_after_display":"3,885,951","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-31","filed_date":"2021-01-05","scope":"insider","n_lines":2},{"id":2462801,"accession":"0000899243-20-035506","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-035506","line_url":"/filing/0000899243-20-035506","is_derivative":false,"issuer_cik":"0001402479","issuer_name":"MedAvail Holdings, Inc.","issuer_ticker":"MDVL","issuer_name_source":null,"issuer_url":"/issuer/0001402479","owner_cik":null,"owner_name":"ABG-WTT Global Life Science Capital Partners GP Ltd; Ally Bridge MedAlpha Management GP, LLC; Yu Fan; ABG-WTT Global Life Science Capital Partners GP, L.P.; Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.; Ally Bridge MedAlpha Master Fund L.P.; Ally Bridge Group (NY) LLC; ABG WTT-MedAvail Ltd; ABG Management Ltd.; Ally Bridge MedAlpha Management L.P.","owner_display_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":1400.0,"total_display":"1,400.00","total_whole":"1,400","shares_owned_after":3879008.0,"shares_owned_after_display":"3,879,008","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-29","filed_date":"2020-12-30","scope":"insider","n_lines":2},{"id":2462789,"accession":"0000899243-20-035506","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-035506","line_url":"/filing/0000899243-20-035506","is_derivative":false,"issuer_cik":"0001402479","issuer_name":"MedAvail Holdings, Inc.","issuer_ticker":"MDVL","issuer_name_source":null,"issuer_url":"/issuer/0001402479","owner_cik":null,"owner_name":"ABG-WTT Global Life Science Capital Partners GP Ltd; Ally Bridge MedAlpha Management GP, LLC; Yu Fan; ABG-WTT Global Life Science Capital Partners GP, L.P.; Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.; Ally Bridge MedAlpha Master Fund L.P.; Ally Bridge Group (NY) LLC; ABG WTT-MedAvail Ltd; ABG Management Ltd.; Ally Bridge MedAlpha Management L.P.","owner_display_name":"ABG-WTT Global Life Science Capital Partners GP Ltd","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7107.0,"shares_display":"7,107","price_per_share":13.9766,"price_display":"13.98","price_state":"stated","total_value":99331.6962,"total_display":"99,331.70","total_whole":"99,332","shares_owned_after":3878953.0,"shares_owned_after_display":"3,878,953","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-28","filed_date":"2020-12-30","scope":"insider","n_lines":2},{"id":2133737,"accession":"0000899243-20-035198","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-035198","line_url":"/filing/0000899243-20-035198","is_derivative":false,"issuer_cik":"0001402479","issuer_name":"MedAvail Holdings, Inc.","issuer_ticker":"MDVL","issuer_name_source":null,"issuer_url":"/issuer/0001402479","owner_cik":null,"owner_name":"Ally Bridge Group (NY) LLC; Ally Bridge MedAlpha Management L.P.; ABG Management Ltd.; ABG-WTT Global Life Science Capital Partners GP Ltd; ABG-WTT Global Life Science Capital Partners GP, L.P.; Ally Bridge MedAlpha Management GP, LLC; Yu Fan; ABG WTT-MedAvail Ltd; Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.; Ally Bridge MedAlpha Master Fund L.P.","owner_display_name":"Ally Bridge Group (NY) LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8890.0,"shares_display":"8,890","price_per_share":13.9919,"price_display":"13.99","price_state":"stated","total_value":124387.991,"total_display":"124,387.99","total_whole":"124,388","shares_owned_after":3875059.0,"shares_owned_after_display":"3,875,059","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-24","filed_date":"2020-12-28","scope":"insider","n_lines":2},{"id":2133729,"accession":"0000899243-20-035198","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-035198","line_url":"/filing/0000899243-20-035198","is_derivative":false,"issuer_cik":"0001402479","issuer_name":"MedAvail Holdings, Inc.","issuer_ticker":"MDVL","issuer_name_source":null,"issuer_url":"/issuer/0001402479","owner_cik":null,"owner_name":"Ally Bridge Group (NY) LLC; Ally Bridge MedAlpha Management L.P.; ABG Management Ltd.; ABG-WTT Global Life Science Capital Partners GP Ltd; ABG-WTT Global Life Science Capital Partners GP, L.P.; Ally Bridge MedAlpha Management GP, LLC; Yu Fan; ABG WTT-MedAvail Ltd; Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.; Ally Bridge MedAlpha Master Fund L.P.","owner_display_name":"Ally Bridge Group (NY) LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21700.0,"shares_display":"21,700","price_per_share":13.9865,"price_display":"13.99","price_state":"stated","total_value":303507.05,"total_display":"303,507.05","total_whole":"303,507","shares_owned_after":3870188.0,"shares_owned_after_display":"3,870,188","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-23","filed_date":"2020-12-28","scope":"insider","n_lines":2},{"id":2133723,"accession":"0000899243-20-035198","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-035198","line_url":"/filing/0000899243-20-035198","is_derivative":false,"issuer_cik":"0001402479","issuer_name":"MedAvail Holdings, Inc.","issuer_ticker":"MDVL","issuer_name_source":null,"issuer_url":"/issuer/0001402479","owner_cik":null,"owner_name":"Ally Bridge Group (NY) LLC; Ally Bridge MedAlpha Management L.P.; ABG Management Ltd.; ABG-WTT Global Life Science Capital Partners GP Ltd; ABG-WTT Global Life Science Capital Partners GP, L.P.; Ally Bridge MedAlpha Management GP, LLC; Yu Fan; ABG WTT-MedAvail Ltd; Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.; Ally Bridge MedAlpha Master Fund L.P.","owner_display_name":"Ally Bridge Group (NY) LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16948.0,"shares_display":"16,948","price_per_share":13.7016,"price_display":"13.70","price_state":"stated","total_value":232214.7168,"total_display":"232,214.72","total_whole":"232,215","shares_owned_after":3858298.0,"shares_owned_after_display":"3,858,298","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-22","filed_date":"2020-12-28","scope":"insider","n_lines":2},{"id":3320287,"accession":"0000899243-20-034836","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-034836","line_url":"/filing/0000899243-20-034836","is_derivative":false,"issuer_cik":"0001402479","issuer_name":"MedAvail Holdings, Inc.","issuer_ticker":"MDVL","issuer_name_source":null,"issuer_url":"/issuer/0001402479","owner_cik":null,"owner_name":"ABG Management Ltd.; Ally Bridge MedAlpha Master Fund L.P.; Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.; Ally Bridge MedAlpha Management L.P.; Ally Bridge MedAlpha Management GP, LLC; Ally Bridge Group (NY) LLC; ABG-WTT Global Life Science Capital Partners GP, L.P.; Yu Fan; ABG-WTT Global Life Science Capital Partners GP Ltd; ABG WTT-MedAvail Ltd","owner_display_name":"ABG Management Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16277.0,"shares_display":"16,277","price_per_share":13.3147,"price_display":"13.31","price_state":"stated","total_value":216723.3719,"total_display":"216,723.37","total_whole":"216,723","shares_owned_after":3849011.0,"shares_owned_after_display":"3,849,011","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-22","scope":"insider","n_lines":2},{"id":3320280,"accession":"0000899243-20-034836","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-034836","line_url":"/filing/0000899243-20-034836","is_derivative":false,"issuer_cik":"0001402479","issuer_name":"MedAvail Holdings, Inc.","issuer_ticker":"MDVL","issuer_name_source":null,"issuer_url":"/issuer/0001402479","owner_cik":null,"owner_name":"ABG Management Ltd.; Ally Bridge MedAlpha Master Fund L.P.; Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.; Ally Bridge MedAlpha Management L.P.; Ally Bridge MedAlpha Management GP, LLC; Ally Bridge Group (NY) LLC; ABG-WTT Global Life Science Capital Partners GP, L.P.; Yu Fan; ABG-WTT Global Life Science Capital Partners GP Ltd; ABG WTT-MedAvail Ltd","owner_display_name":"ABG Management Ltd.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18600.0,"shares_display":"18,600","price_per_share":13.5946,"price_display":"13.59","price_state":"stated","total_value":252859.56,"total_display":"252,859.56","total_whole":"252,860","shares_owned_after":3840092.0,"shares_owned_after_display":"3,840,092","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-18","filed_date":"2020-12-22","scope":"insider","n_lines":2},{"id":2685424,"accession":"0000899243-20-034482","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-034482","line_url":"/filing/0000899243-20-034482","is_derivative":false,"issuer_cik":"0001402479","issuer_name":"MedAvail Holdings, Inc.","issuer_ticker":"MDVL","issuer_name_source":null,"issuer_url":"/issuer/0001402479","owner_cik":null,"owner_name":"Ally Bridge MedAlpha Management L.P.; ABG-WTT Global Life Science Capital Partners GP Ltd; Ally Bridge MedAlpha Management GP, LLC; ABG-WTT Global Life Science Capital Partners GP, L.P.; ABG Management Ltd.; Yu Fan; ABG WTT-MedAvail Ltd; Ally Bridge Group (NY) LLC; Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.; Ally Bridge MedAlpha Master Fund L.P.","owner_display_name":"Ally Bridge MedAlpha Management L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14954.0,"shares_display":"14,954","price_per_share":13.254079691052562,"price_display":"13.25","price_state":"stated","total_value":198201.5077,"total_display":"198,201.51","total_whole":"198,202","shares_owned_after":3828652.0,"shares_owned_after_display":"3,828,652","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-17","filed_date":"2020-12-18","scope":"insider","n_lines":4},{"id":2685408,"accession":"0000899243-20-034482","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-034482","line_url":"/filing/0000899243-20-034482","is_derivative":false,"issuer_cik":"0001402479","issuer_name":"MedAvail Holdings, Inc.","issuer_ticker":"MDVL","issuer_name_source":null,"issuer_url":"/issuer/0001402479","owner_cik":null,"owner_name":"Ally Bridge MedAlpha Management L.P.; ABG-WTT Global Life Science Capital Partners GP Ltd; Ally Bridge MedAlpha Management GP, LLC; ABG-WTT Global Life Science Capital Partners GP, L.P.; ABG Management Ltd.; Yu Fan; ABG WTT-MedAvail Ltd; Ally Bridge Group (NY) LLC; Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.; Ally Bridge MedAlpha Master Fund L.P.","owner_display_name":"Ally Bridge MedAlpha Management L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28429.0,"shares_display":"28,429","price_per_share":13.0611,"price_display":"13.06","price_state":"stated","total_value":371314.0119,"total_display":"371,314.01","total_whole":"371,314","shares_owned_after":3821706.0,"shares_owned_after_display":"3,821,706","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-16","filed_date":"2020-12-18","scope":"insider","n_lines":2},{"id":3204090,"accession":"0000899243-20-034209","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000899243-20-034209","line_url":"/filing/0000899243-20-034209","is_derivative":false,"issuer_cik":"0001402479","issuer_name":"MedAvail Holdings, Inc.","issuer_ticker":"MDVL","issuer_name_source":null,"issuer_url":"/issuer/0001402479","owner_cik":null,"owner_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.; ABG-WTT Global Life Science Capital Partners GP Ltd; Ally Bridge Group (NY) LLC; Ally Bridge MedAlpha Management L.P.; ABG Management Ltd.; Ally Bridge MedAlpha Master Fund L.P.; Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.; Ally Bridge MedAlpha Management GP, LLC; ABG WTT-MedAvail Ltd; Yu Fan","owner_display_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29429.0,"shares_display":"29,429","price_per_share":12.893536474226103,"price_display":"12.89","price_state":"stated","total_value":379443.8849,"total_display":"379,443.88","total_whole":"379,444","shares_owned_after":3806128.0,"shares_owned_after_display":"3,806,128","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-16","scope":"insider","n_lines":4},{"id":3204079,"accession":"0000899243-20-034209","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-034209","line_url":"/filing/0000899243-20-034209","is_derivative":false,"issuer_cik":"0001402479","issuer_name":"MedAvail Holdings, Inc.","issuer_ticker":"MDVL","issuer_name_source":null,"issuer_url":"/issuer/0001402479","owner_cik":null,"owner_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.; ABG-WTT Global Life Science Capital Partners GP Ltd; Ally Bridge Group (NY) LLC; Ally Bridge MedAlpha Management L.P.; ABG Management Ltd.; Ally Bridge MedAlpha Master Fund L.P.; Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.; Ally Bridge MedAlpha Management GP, LLC; ABG WTT-MedAvail Ltd; Yu Fan","owner_display_name":"ABG-WTT Global Life Science Capital Partners GP, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14457.0,"shares_display":"14,457","price_per_share":12.2443,"price_display":"12.24","price_state":"stated","total_value":177015.8451,"total_display":"177,015.85","total_whole":"177,016","shares_owned_after":3790002.0,"shares_owned_after_display":"3,790,002","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-14","filed_date":"2020-12-16","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001402479","name":"MedAvail Holdings, Inc.","url":"/issuer/0001402479","role":"Ten percent owner","n_filings":6,"first_seen":"2020-12-16","last_seen":"2021-01-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001766516","retrieved_at":"2026-08-23T19:47:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}